Bleakley is associate professor and director of cellular therapy and transplantation for pediatric leukemia in the clinical research division, Gerdin family endowed chair for leukemia research and associate professor of pediatrics at University of Washington School of Medicine.
Chimeric antigen receptor T-cell therapy targeting CD19 is highly effective for inducing remission among patients with relapsed or refractory B-cell acute lymphoblastic leukemia.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.